DocGo

DocGo, Inc. engages in the provision of mobile health services. It operates through the following segments: Transportation Services and Mobile Health Solutions. The Transportation Services segment offers on-demand medical mobility solutions which are marketed under the Ambulnz brand. The Mobile Health Solutions segment includes on-site evaluations, diagnostics, triage, treatment, and medicine administration. The company was founded in 2015 by Stanley Vashovsky and is headquartered in New York, NY.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

DocGo reports stellar 2022 performance and outlines growth strategies

DocGo's strong financial performance in 2022, coupled with robust guidance for 2023 and strategic operational initiatives, positions the company for continued growth and profitability.
While challenges like managing PHE impacts and transitioning to leased hour contracts exist, DocGo's proactive approach and operational strengths provide a solid foundation for addressing these hurdles.
With a focus on optimizing operations, pursuing growth opportunities, and leveraging its financial resources effectively, DocGo is poised to capitalize on market opportunities and deliver value to stakeholders.

DocGo reports Q1 revenue growth amidst margin challenges and future opportunities

DocGo's Q1 2023 performance showcased revenue growth and margin challenges, with a focus on improving margins through normalization initiatives.
Strengths include strong revenue guidance, significant contract opportunities, and partnerships driving backlog growth and revenue diversification.
Challenges stem from replacing high-margin COVID revenue, startup costs impacting margins, and negative cash flow in Q1 2023.
Opportunities lie in future revenue growth from new contracts, RPM services, public-private partnerships, and potential contract wins from upcoming RFPs.

DocGo (DCGO) reports stellar Q2 results, raises full-year guidance

DocGo's Q2 2023 showcased exceptional financial performance, with revenue and EBITDA growth exceeding expectations, underpinned by strong operational metrics and strategic decisions.
While facing challenges in backlog conversion and margin improvements, the company's focus on scalability, employee satisfaction, and market expansion positions it well for future growth.
Opportunities in new geographies, Remote Patient Monitoring integration, and transportation segment enhancements provide avenues for sustained revenue growth and operational excellence.

DocGo reports record Q3 revenue, eyes growth in commercial sector

DocGo's Q3 performance reflects strong revenue growth and improved EBITDA margins, driven by the success of Mobile Health and Transportation Services. While facing challenges with working capital and payment delays, the company is focused on catching up by year-end.
The company's strengths in contract performance, revenue guidance increase, and backlog diversification position it well for future growth. DocGo's strategic focus on commercial business expansion and customer experience enhancement aligns with its growth objectives.

DocGo reports record Q4 earnings, eyes growth in healthcare

DocGo delivered exceptional financial results in Q4 2023, showcasing robust revenue growth and profitability, driven by operational excellence and strategic investments.
While facing margin and cost challenges, the company's focus on growth, value-based care agreements, and revenue diversification positions it well for future success and market expansion.
With a strong cash position, revised revenue guidance, and proactive pursuit of new partnerships, DocGo is poised to capitalize on growth opportunities and navigate challenges effectively.
The company's commitment to transforming healthcare delivery and gratitude towards its staff underscore a resilient corporate culture and a dedication to driving positive impact in the industry.

DocGo reports robust Q1 earnings, eyes growth through unique care model

DocGo's Q1 2024 performance was strong, marked by revenue growth, improved margins, and profitability.
While facing challenges like revenue fluctuations and working capital pressures, the company is well-positioned for growth.
Opportunities lie in becoming a primary care provider, monetization strategies, and market differentiation through quality care.
Overall, DocGo's financial stability, growth plans, and unique service offerings position them for future success in the healthcare sector.

DocGo excels in Q2 2024, sets sights on clinical innovation

DocGo's Q2 2024 performance reflects financial strength and strategic advancements in clinical expertise and service expansion.
While facing challenges in meeting ambitious care gap closure targets, the company is well-positioned for growth.
Leveraging opportunities in mobile healthcare services and clinical program development can drive future success for DocGo.

DocGo reports robust Q3 earnings, eyes growth in migrant-related work

DocGo's Q3 2024 earnings call showcased strong financial performance, operational efficiency, and positive outlook for future revenue and cash flow.
While challenges such as revenue balancing and margin expectations were noted, opportunities for growth through migrant-related work and care programs were highlighted.
Overall, DocGo's performance and strategic direction position the company well for continued success and expansion in the healthcare sector.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

DocGo, Inc. engages in the provision of mobile health services. It operates through the following segments: Transportation Services, Mobile Health Solutions, and Corporate. The Transportation Services segment offers on-demand medical mobility solutions which are marketed under the Ambulnz brand. The Mobile Health Solutions segment includes on-site evaluations, diagnostics, triage, treatment, and medicine administration. The Corporate segment consists of information technology expenses. The company was founded in 2015 by Stanley Vashovsky and is headquartered in New York, NY.

NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced the establishment of its Medical Advisory Board (MAB) to offer counsel and expertise to the Company's executive team. The MAB will help further propel DocGo's mission to deliver top-tier virtual, in-person, and mobile healthcare services across the US and UK. Members will provide guidance and act as a resource for DocGo's ongoing effor.

DocGo Establishes Medical Advisory Board

LOS ANGELES, CA / ACCESSWIRE / June 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of DocGo Inc. ("DocGo" or "the Company") (NASDAQ:DCGO) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Allegations Against DocGo Inc.: Schall Law Firm Begins Investigation And Encourages Affected Investors To Reach Out

LOS ANGELES, CA / ACCESSWIRE / June 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of DocGo Inc. ("DocGo" or "the Company") (NASDAQ:DCGO) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Charges Against DocGo Inc.: Schall Law Firm Launches Examination And Calls On Affected Investors To Participate

LOS ANGELES, CA / ACCESSWIRE / June 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of DocGo Inc. ("DocGo" or "the Company") (NASDAQ:DCGO) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Accusations Against DocGo Inc.: Schall Law Firm Initiates Inquiry And Invites Impacted Investors To Engage

LOS ANGELES, CA / ACCESSWIRE / June 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of DocGo Inc. ("DocGo" or "the Company") (NASDAQ:DCGO) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Claims Against DocGo Inc.: Schall Law Firm Begins Probe And Calls On Affected Investors To Connect

LOS ANGELES, CA / ACCESSWIRE / June 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of DocGo Inc. ("DocGo" or "the Company") (NASDAQ:DCGO) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Allegations Against DocGo Inc.: Schall Law Firm Initiates Investigation And Invites Impacted Investors To Reach Out

LOS ANGELES, CA / ACCESSWIRE / June 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of DocGo Inc. ("DocGo" or "the Company") (NASDAQ:DCGO) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

DocGo Inc. Allegations: Schall Law Firm Begins Inquiry and Encourages Affected Investors to Connect

LOS ANGELES, CA / ACCESSWIRE / June 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of DocGo Inc. ("DocGo" or "the Company") (NASDAQ:DCGO) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

The Schall Law Firm is starting an inquiry into allegations against DocGo Inc. and encourages investors who have experienced losses to reach out

LOS ANGELES, CA / ACCESSWIRE / June 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of DocGo Inc. ("DocGo" or "the Company") (NASDAQ:DCGO) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

DCGO IMPORTANT ACTION UPDATE: The Schall Law Firm Announces it is Investigating Claims Against DocGo Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / June 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of DocGo Inc. ("DocGo" or "the Company") (NASDAQ:DCGO) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

CRUCIAL INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against DocGo Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / June 1, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of DocGo Inc. ("DocGo" or "the Company") (NASDAQ:DCGO) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

CRUCIAL INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against DocGo Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / May 31, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of DocGo Inc. ("DocGo" or "the Company") (NASDAQ:DCGO) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

CRUCIAL INVESTIGATION UPDATE: The Schall Law Firm Announces it is Investigating Claims Against DocGo Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / May 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of DocGo Inc. ("DocGo" or "the Company") (NASDAQ:DCGO) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against DocGo Inc. and Encourages Investors with Losses to Contact the Firm

NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health services, today announced that Lee Bienstock, Chief Executive Officer, will present at the Stifel Cross Sector Insight Conference on Wednesday, June 5 at 1:15 PM Eastern Time. A webcast of the event will be available on the investor relations section of DocGo's website at https://ir.docgo.com/. About DocGo DocGo is leading the proactive healthcare revolution with an innovative.

DocGo Announces Upcoming Participation at Stifel Cross Sector Insight Conference

LOS ANGELES, CA / ACCESSWIRE / May 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of DocGo Inc. ("DocGo" or "the Company") (NASDAQ:DCGO) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against DocGo Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / May 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of DocGo Inc. ("DocGo" or "the Company") (NASDAQ:DCGO) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

IMPORTANT SHAREHOLDER INVESTIGATION: The Schall Law Firm Announces it is Investigating Claims Against DocGo Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / May 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of DocGo Inc. ("DocGo" or "the Company") (NASDAQ:DCGO) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against DocGo Inc. and Encourages Investors with Losses to Contact the Firm

DocGo Inc. (NASDAQ:DCGO ) Q1 2024 Earnings Conference Call May 8, 2024 5:00 PM ET Company Participants Mike Cole - Director, Investor Relations Lee Bienstock - Chief Executive Officer Norman Rosenberg - Chief Financial Officer Conference Call Participants Ryan MacDonald - Needham Richard Close - Canaccord Genuity David Larsen - BTIG Kieran Ryan - Deutsche Bank Sarah James - Cantor Fitzgerald David Grossman - Stifel Operator Greetings and welcome to the DocGo First Quarter 2024 Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded.

DocGo Inc. (DCGO) Q1 2024 Earnings Call Transcript

DocGo Inc. (DCGO) came out with quarterly earnings of $0.09 per share, in line with the Zacks Consensus Estimate. This compares to loss of $0.03 per share a year ago.

DocGo Inc. (DCGO) Matches Q1 Earnings Estimates

NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced financial and operating results for the quarter ended March 31, 2024. First Quarter 2024 Financial Highlights Total revenue for the first quarter of 2024 was $192.1 million, compared to $113.0 million in the first quarter of 2023, an increase of 70%. Gross margin for the first quarter of 2024 was 35.0%, compared to the gross margin in.

DocGo Announces Strong First Quarter 2024 Results

Motion Acquisition (DCGO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

DocGo Inc. (DCGO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, announced today that the Company will release its financial results for the first quarter ended March 31, 2024 after the markets close on Wednesday, May 8, 2024. Management will also host a conference call to discuss these results at 5:00 p.m. ET on that day. Conference call and webcast details: Wednesday, May 8, 2024 5:00 p.m. ET 1-877-407-0784 (U.S.

DocGo to Announce First Quarter 2024 Results on Wednesday, May 8, 2024

LOS ANGELES, CA / ACCESSWIRE / April 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of DocGo Inc. ("DocGo" or "the Company") (NASDAQ:DCGO) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against DocGo Inc. and Encourages Investors with Losses to Contact the Firm

NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, announced today the extension of its current migrant services contract with the New York City Department of Housing Preservation and Development (HPD). This extension is part of a planned transition that DocGo worked on in collaboration with NYC, demonstrating a continued partnership to ensure consistent and quality services for those in need. Under t.

DocGo Signs Extension and Begins Planned Transition of Asylum Seeker Contract with New York City HPD

LOS ANGELES, CA / ACCESSWIRE / April 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of DocGo Inc. ("DocGo" or "the Company") (NASDAQ:DCGO) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against DocGo Inc. and Encourages Investors with Losses to Contact the Firm

News for DocGo Stock (DCGO)